FDA Approvals - Smith & Nephew Receives FDA Approval for EXOGEN 4000+(TM) Bone
Smith & Nephew Receives FDA Approval for EXOGEN 4000+(TM) Bone Healing System (FinanzNachrichten)
MEMPHIS, Tenn., July 18 /PRNewswire-FirstCall/ -- Smith&Nephew's Orthopaedic Trauma&Clinical Therapies division today announced FDA approval for its EXOGEN 4000+(TM) Bone Healing System.
Lupin Announces Approval of Meloxicam Tablets (RedNova)
BALTIMORE, July 20 /PRNewswire/ -- Lupin Pharmaceuticals, Inc. announced today that the U.S. Food and Drug Administration (FDA) has granted final approval for its Abbreviated New Drug Application (ANDA) for Meloxicam Tablets, 7.5 mg and 15 mg.